中华肝胆外科杂志
中華肝膽外科雜誌
중화간담외과잡지
CHINESE JOURNAL OF HEPATOBILIARY SURGERY
2012年
3期
166-168
,共3页
刘立国%吴凡%吴健雄%王黎明%荣维淇%钟宇新%徐泉%王一澎%苗成利
劉立國%吳凡%吳健雄%王黎明%榮維淇%鐘宇新%徐泉%王一澎%苗成利
류입국%오범%오건웅%왕려명%영유기%종우신%서천%왕일팽%묘성리
肝脏%肝细胞腺瘤%肝切除术%诊断
肝髒%肝細胞腺瘤%肝切除術%診斷
간장%간세포선류%간절제술%진단
Liver%Hepatocellular adenoma%Hepatectomy%Diagnosis
目的 探讨肝细胞腺瘤(hepatocellular adenoma,HCA)及肝腺瘤病(liver adenomatosis,LA)的临床表现、治疗方法和预后.方法 回顾性分析经手术治疗的10例HCA及1例LA患者的临床资料.结果 本组女性发病居多,共7例(63.6%),1例女性肝腺瘤病患者有口服避孕药病史.全组中位发病年龄33(范围25~70)岁.多数无临床症状(72.7%).肿瘤标记物CA19-9和甲胎蛋白(AFP)正常.超声造影、CT及磁共振(MRI)增强扫描多提示病灶动脉期强化,门脉期、延迟期去强化.组织病理提示10例为单发病灶,诊断HCA,其中1例肿瘤细胞轻度异型及不典型增生,1例存在细胞不典型增生,1例细胞生长活跃;另外1例为多发病灶,细胞存在异型,诊断肝腺瘤病.11例患者均经手术切除,经随访21~125个月,无复发.结论 HCA患者多无明显临床表现,肝脂肪变性可能为HCA和LA的共同病因,口服避孕药物可能为LA的病因.动态影像学检查有助于诊断,HCA有病灶破裂出血及癌变危险,首选手术治疗,预后良好.
目的 探討肝細胞腺瘤(hepatocellular adenoma,HCA)及肝腺瘤病(liver adenomatosis,LA)的臨床錶現、治療方法和預後.方法 迴顧性分析經手術治療的10例HCA及1例LA患者的臨床資料.結果 本組女性髮病居多,共7例(63.6%),1例女性肝腺瘤病患者有口服避孕藥病史.全組中位髮病年齡33(範圍25~70)歲.多數無臨床癥狀(72.7%).腫瘤標記物CA19-9和甲胎蛋白(AFP)正常.超聲造影、CT及磁共振(MRI)增彊掃描多提示病竈動脈期彊化,門脈期、延遲期去彊化.組織病理提示10例為單髮病竈,診斷HCA,其中1例腫瘤細胞輕度異型及不典型增生,1例存在細胞不典型增生,1例細胞生長活躍;另外1例為多髮病竈,細胞存在異型,診斷肝腺瘤病.11例患者均經手術切除,經隨訪21~125箇月,無複髮.結論 HCA患者多無明顯臨床錶現,肝脂肪變性可能為HCA和LA的共同病因,口服避孕藥物可能為LA的病因.動態影像學檢查有助于診斷,HCA有病竈破裂齣血及癌變危險,首選手術治療,預後良好.
목적 탐토간세포선류(hepatocellular adenoma,HCA)급간선류병(liver adenomatosis,LA)적림상표현、치료방법화예후.방법 회고성분석경수술치료적10례HCA급1례LA환자적림상자료.결과 본조녀성발병거다,공7례(63.6%),1례녀성간선류병환자유구복피잉약병사.전조중위발병년령33(범위25~70)세.다수무림상증상(72.7%).종류표기물CA19-9화갑태단백(AFP)정상.초성조영、CT급자공진(MRI)증강소묘다제시병조동맥기강화,문맥기、연지기거강화.조직병리제시10례위단발병조,진단HCA,기중1례종류세포경도이형급불전형증생,1례존재세포불전형증생,1례세포생장활약;령외1례위다발병조,세포존재이형,진단간선류병.11례환자균경수술절제,경수방21~125개월,무복발.결론 HCA환자다무명현림상표현,간지방변성가능위HCA화LA적공동병인,구복피잉약물가능위LA적병인.동태영상학검사유조우진단,HCA유병조파렬출혈급암변위험,수선수술치료,예후량호.
Objective To review the clinical features,therapeutic approach and prognosis of hepatocellular adenoma(HCA)and liver adenomatosis(LA).Methods The clinical data from patients with histopathological diagnosis confirmed on operative specimens were analyzed retrospectively.Results There were 10 patients with HCA and 1 with LA.The disease was found mainly in females (n=7,63.6%),and only one female patient with LA had a history of use of oral contraceptive.The median age at presentation was 33 years(range,25-70 years).Most patients(n=8,72.7%)had no significant symptom.Tumor markers including CA19-9 and alpha fetoprotein(AFP)were normal.On dynamic ultrasonography,CT and MRI,most lesions showed contrast enhancement in the arterial phase and washout in the portal venous phase and delayed phase.For the 10 patients with HCA,the lesion was solitary.On histopathology,atypia and dysplasia were present in 1 patient,dysplasia in 1 patient,and active tumor cell growth in 1 patient.The patients with liver adenomatosis had multiple lesions and atypia.All patients underwent liver resection.There was no recurrence on follow-up which ranged from 21 to 125 months.Conclusions Most patients had no clinical symptoms.Hepatic steato sis may be a potential cause for HCA and LA.Oral contraceptive plays an important role in the patho genesis of LA.Dynamic imaging examinations were helpful for diagnosis.In view of the associated risks of hemorrhage and malignant transformation,surgical resection is the optimal treatment.The prognosis is good.